DMIIU · Drugs Made In America Acquisition II Corp. · Analyst Estimates
$10.23
-0.02 (-0.19%)
At close · Oct 13
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“management has determined that these conditions raise substantial doubt about the Company's ability to continue as a going concern within one year after the date that the financial statements are issued. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.”View the 10-Q filed Aug 14, 2026
Market Cap
$649.42M
Shares
63.70M
Volume · Oct 13
4200
Avg daily vol (3M)
1687
Analyst Estimates
Compare analyst forecasts for Drugs Made In America Acquisition II Corp. across metrics and forecast periods.
Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.
Compiled consensus
This verified capture contains no analyst forecast observations. Older snapshots remain in the history.
Captured 2026-09-18 02:58 UTC · Publication dates shown per estimate · 0 metric / period groups
Key facts
CIK
2040475
CUSIP
G2851K104